Difference between revisions of "Template:Main page"
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
<li>[[Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis]]</li> | <li>[[Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis]]</li> | ||
<li>[[Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19]]</li> | <li>[[Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19]]</li> | ||
| + | <li>[[COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study]]</li> | ||
<li>[[Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis]]</li> | <li>[[Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis]]</li> | ||
</ul> | </ul> | ||
Revision as of 20:01, 22 July 2020
OMNIJOURNAL
Peer-review by everyone
COVID-19 Pandemic
- Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Recently Edited
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
- Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic
- Vitamin D deficiency causes a 10 times higher death rate in Covid-19 patients
- Early treatment with hydroxychloroquine: a country-randomized controlled trial